[A case of tuberculosis that occurred during treatment of hepatocellular carcinoma with sorafenib].

A 66-year-old man with hepatocellular carcinoma (HCC) and suspicion of lung metastasis consulted us because of an abnormal chest shadow as seen on a radiograph. He had been treated with sorafenib for 2 months. A chest CT scan showed cavitating nodules in the left upper lobe that were present before therapy with sorafenib, and infiltrative shadows in the subpleural areas of the right upper lobe. The shadows were diagnosed, at least in part, as pulmonary tuberculosis by using a nucleic acid amplification test for Mycobacterium tuberculosis in the sputum that yielded a positive result. Treatment with antituberculosis drugs resulted in a good clinical response. However, the patient died of HCC. We concluded that the nodule in the right upper lobe was old pulmonary tuberculosis, because it did not change during the course of the disease and because the cavities in the left upper lobe were active lesions. Sorafenib is a molecularly targeted agent that has been proven effective for treating advanced HCC with extrahepatic metastasis. It may also cause necrosis within lung metastases as an anti-tumor effect. Therefore, pulmonary tuberculosis, including reactivation, should be considered in the differential diagnosis when treating a patient with sorafenib.
AuthorsYusuke Kobayashi, Masahito Emura, Takaya Nakamura, Takanori Cho, Ruriko Seto, Natsuko Nomura, Takeshi Nomizo, Shuta Igarashi
JournalKekkaku : [Tuberculosis] (Kekkaku) Vol. 88 Issue 9 Pg. 671-5 (Sep 2013) ISSN: 0022-9776 [Print] Japan
PMID24298694 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Antineoplastic Agents
  • Phenylurea Compounds
  • Niacinamide
  • sorafenib
  • Aged
  • Antineoplastic Agents (adverse effects)
  • Carcinoma, Hepatocellular (drug therapy)
  • Humans
  • Liver Neoplasms (drug therapy)
  • Male
  • Niacinamide (adverse effects, analogs & derivatives)
  • Phenylurea Compounds (adverse effects)
  • Tuberculosis, Pulmonary (etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: